| Size | Price | Stock | Qty |
|---|---|---|---|
| 5mg |
|
||
| Other Sizes |
| Targets |
Targets microtubules, stabilizing them against depolymerization, which disrupts cell division; similar to other taxanes.
|
|---|---|
| ln Vitro |
Shows significant antinociceptive activity in the p-benzoquinone-induced abdominal contraction model; inhibits microtubule depolymerization in cell-free assays (1 microg/mL).
|
| ln Vivo |
Demonstrates in vivo antinociceptive effects by reducing p-benzoquinone-induced abdominal contractions, indicating pain-relieving properties.
|
| Enzyme Assay |
Cell-free tubulin polymerization assay: incubate purified tubulin with compound (1 microg/mL), measure turbidity at 340nm to monitor microtubule assembly inhibition/stabilization.
|
| Cell Assay |
Cell-based microtubule stabilization assay: treat MDR cancer cells with compound, stain with anti-tubulin antibody, visualize microtubule network via fluorescence microscopy to assess stabilization.
|
| Animal Protocol |
In vivo antinociception: administer compound (dose not specified) to mice, inject p-benzoquinone IP, count abdominal constrictions over 5-10 min to measure pain relief efficacy.
|
| ADME/Pharmacokinetics |
No detailed PK data available; as a natural taxoid, it likely has poor oral bioavailability and is primarily used for structural studies or as a synthetic intermediate.
|
| Toxicity/Toxicokinetics |
No detailed toxicity data available; expected to have manageable toxicity based on taxane family profile, but not for direct therapeutic use.
|
| References | |
| Additional Infomation |
According to reports, 1-hydroxybaccatin I has been found in Taxus cuspidata, Taxus wallichiana, and Taxus brevifolia, and relevant data are available for reference.
Beyond microtubule stabilization, it is a key precursor for semi-synthetic paclitaxel and its analogs. Found in multiple Taxus species, it has no approved clinical status but is vital for cancer research and drug development. |
| Molecular Formula |
C32H44O14
|
|---|---|
| Molecular Weight |
652.68
|
| Exact Mass |
652.273
|
| CAS # |
30244-37-2
|
| PubChem CID |
14466616
|
| Appearance |
White to off-white solid
|
| Density |
1.3±0.1 g/cm3
|
| Boiling Point |
657.2±55.0 °C at 760 mmHg
|
| Flash Point |
197.6±25.0 °C
|
| Vapour Pressure |
0.0±4.5 mmHg at 25°C
|
| Index of Refraction |
1.542
|
| Source |
Originated from plants: Taxaceae Taxus wallichiana Zucc.
|
| LogP |
2.15
|
| Hydrogen Bond Donor Count |
1
|
| Hydrogen Bond Acceptor Count |
14
|
| Rotatable Bond Count |
12
|
| Heavy Atom Count |
46
|
| Complexity |
1370
|
| Defined Atom Stereocenter Count |
10
|
| SMILES |
O1C([H])([H])C21C([H])(C([H])([H])C([H])(C1(C([H])([H])[H])C([H])(C([H])(C3=C(C([H])([H])[H])C([H])(C([H])([H])C(C3(C([H])([H])[H])C([H])([H])[H])(C([H])(C21[H])OC(C([H])([H])[H])=O)O[H])OC(C([H])([H])[H])=O)OC(C([H])([H])[H])=O)OC(C([H])([H])[H])=O)OC(C([H])([H])[H])=O)OC(C([H])([H])[H])=O
|
| InChi Key |
LUTPIRPNUNHFEV-MBMCFSISSA-N
|
| InChi Code |
InChI=1S/C32H44O14/c1-14-21(41-15(2)33)12-32(39)28(46-20(7)38)26-30(10,22(42-16(3)34)11-23(43-17(4)35)31(26)13-40-31)27(45-19(6)37)25(44-18(5)36)24(14)29(32,8)9/h21-23,25-28,39H,11-13H2,1-10H3/t21-,22-,23-,25+,26-,27-,28-,30+,31+,32+/m0/s1
|
| Chemical Name |
[(1'S,2R,2'S,3'R,5'S,7'S,8'S,9'R,10'R,13'S)-2',5',9',10',13'-pentaacetyloxy-1'-hydroxy-8',12',15',15'-tetramethylspiro[oxirane-2,4'-tricyclo[9.3.1.03,8]pentadec-11-ene]-7'-yl] acetate
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO: ~50 mg/mL (~76.6 mM; with ultrasonication)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (3.83 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween-80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), Clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of DMSO stock solution (25.0 mg/mL) to 400 μL of PEG300 and mix well; then add 50 μL of Tween-80 and mix well; finally add 450 μL of physiological saline and adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (3.83 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), Clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of DMSO stock solution (25.0 mg/mL) to 900 μL of corn oil and mix well. (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.5321 mL | 7.6607 mL | 15.3214 mL | |
| 5 mM | 0.3064 mL | 1.5321 mL | 3.0643 mL | |
| 10 mM | 0.1532 mL | 0.7661 mL | 1.5321 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
